Header Logo

Connection

Peter Friedmann to Adult

Back to Details
This is a "connection" page, showing publications Peter Friedmann has written about Adult.
Peter Friedmann
Connection Strength
2.382
Adult
  1. Soares WE, Schoenfeld E, Friedmann PD. Precipitated Withdrawal in the Era of Street Fentanyl-The Important Thing Is to Not Stop Questioning. JAMA Netw Open. 2024 Sep 03; 7(9):e2435857.
    View in: PubMed
    Score: 0.072
  2. Romo E, Bianchet E, Dowd P, Mazor KM, Stopka TJ, Friedmann PD. Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States. Viruses. 2024 Aug 27; 16(9).
    View in: PubMed
    Score: 0.072
  3. Michener PS, Bianchet E, Fox S, Evans EA, Friedmann PD. "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder. Harm Reduct J. 2024 07 22; 21(1):138.
    View in: PubMed
    Score: 0.071
  4. Romo E, Stopka TJ, Jesdale BM, Wang B, Mazor KM, Friedmann PD. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States. Harm Reduct J. 2024 01 28; 21(1):23.
    View in: PubMed
    Score: 0.069
  5. Evans EA, Pivovarova E, Senthilkumar R, Rottapel RE, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Int J Drug Policy. 2023 Dec; 122:104252.
    View in: PubMed
    Score: 0.068
  6. Romo E, Rudolph AE, Stopka TJ, Wang B, Jesdale BM, Friedmann PD. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England. Addict Sci Clin Pract. 2023 01 03; 18(1):2.
    View in: PubMed
    Score: 0.064
  7. Evans EA, Wilson D, Friedmann PD. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Depend. 2022 02 01; 231:109254.
    View in: PubMed
    Score: 0.060
  8. Pivovarova E, Min HS, Friedmann PD. Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Subst Abus. 2021; 42(4):618-624.
    View in: PubMed
    Score: 0.054
  9. Peacock-Chambers E, Feinberg E, Senn-McNally M, Clark MC, Jurkowski B, Suchman NE, Byatt N, Friedmann PD. Engagement in Early Intervention Services Among Mothers in Recovery From Opioid Use Disorders. Pediatrics. 2020 02; 145(2).
    View in: PubMed
    Score: 0.052
  10. Paterno MT, Jablonski L, Klepacki A, Friedmann PD. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes. J Obstet Gynecol Neonatal Nurs. 2019 Sep; 48(5):495-506.
    View in: PubMed
    Score: 0.050
  11. Stopka TJ, Jacque E, Kelso P, Guhn-Knight H, Nolte K, Hoskinson R, Jones A, Harding J, Drew A, VanDonsel A, Friedmann PD. The opioid epidemic in rural northern New England: An approach to epidemiologic, policy, and legal surveillance. Prev Med. 2019 11; 128:105740.
    View in: PubMed
    Score: 0.050
  12. Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
    View in: PubMed
    Score: 0.049
  13. Soares WE, Wilson D, Gordon MS, Lee JD, Nunes EV, O'Brien CP, Shroff M, Friedmann PD. Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual. Drug Alcohol Depend. 2019 01 01; 194:482-486.
    View in: PubMed
    Score: 0.048
  14. Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatr Serv. 2018 04 01; 69(4):448-455.
    View in: PubMed
    Score: 0.045
  15. Soares WE, Wilson D, Rathlev N, Lee JD, Gordon M, Nunes EV, O'Brien CP, Friedmann PD. Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual. J Subst Abuse Treat. 2018 02; 85:66-69.
    View in: PubMed
    Score: 0.043
  16. Friedmann PD, Wilson D, Hoskinson R, Poshkus M, Clarke JG. Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison. J Subst Abuse Treat. 2018 02; 85:45-48.
    View in: PubMed
    Score: 0.043
  17. Friedmann PD, Wilson D, Nunes EV, Hoskinson R, Lee JD, Gordon M, Murphy SM, Bonnie RJ, Chen DT, Boney TY, O'Brien CP. Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder? J Subst Abuse Treat. 2018 02; 85:61-65.
    View in: PubMed
    Score: 0.043
  18. Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, Lindsey A, Abdel-Salam S, Wood J, Monico L, Link N, Albizu-Garcia C, Friedmann PD. Effects of an Organizational Linkage Intervention on Inter-Organizational Service Coordination Between Probation/Parole Agencies and Community Treatment Providers. Adm Policy Ment Health. 2016 Jan; 43(1):105-21.
    View in: PubMed
    Score: 0.039
  19. Frank JW, Andrews CM, Green TC, Samuels AM, Trinh TT, Friedmann PD. Emergency department utilization among recently released prisoners: a retrospective cohort study. BMC Emerg Med. 2013 Nov 05; 13:16.
    View in: PubMed
    Score: 0.034
  20. Green TC, Johnson J, Harrington M, Pouget ER, Rhodes AG, Taxman FS, O'Connell DJ, Martin SS, Prendergast M, Friedmann PD. Parole officer-parolee relationships and HIV risk behaviors during community supervision. AIDS Behav. 2013 Oct; 17(8):2667-75.
    View in: PubMed
    Score: 0.034
  21. Cioe PA, Stein MD, Promrat K, Friedmann PD. A comparison of modified directly observed therapy to standard care for chronic hepatitis C. J Community Health. 2013 Aug; 38(4):679-84.
    View in: PubMed
    Score: 0.033
  22. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change pharmacy practice? J Am Pharm Assoc (2003). 2013 May-Jun; 53(3):273-81.
    View in: PubMed
    Score: 0.033
  23. Friedmann PD. Clinical practice. Alcohol use in adults. N Engl J Med. 2013 Jan 24; 368(4):365-73.
    View in: PubMed
    Score: 0.032
  24. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change medical practice? Pain Med. 2012 Oct; 13(10):1314-23.
    View in: PubMed
    Score: 0.031
  25. Green TC, Pouget ER, Harrington M, Taxman FS, Rhodes AG, O'Connell D, Martin SS, Prendergast M, Friedmann PD. Limiting options: sex ratios, incarceration rates, and sexual risk behavior among people on probation and parole. Sex Transm Dis. 2012 Jun; 39(6):424-30.
    View in: PubMed
    Score: 0.031
  26. Friedmann PD, Green TC, Taxman FS, Harrington M, Rhodes AG, Katz E, O'Connell D, Martin SS, Frisman LK, Litt M, Burdon W, Clarke JG, Fletcher BW. Collaborative behavioral management among parolees: drug use, crime and re-arrest in the Step'n Out randomized trial. Addiction. 2012 Jun; 107(6):1099-108.
    View in: PubMed
    Score: 0.030
  27. Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O'Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus. 2012; 33(1):9-18.
    View in: PubMed
    Score: 0.030
  28. Friedmann PD, Jiang L, Alexander JA. Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs. J Behav Health Serv Res. 2010 Jul; 37(3):322-37.
    View in: PubMed
    Score: 0.025
  29. Friedmann PD, Rose JS, Swift R, Stout RL, Millman RP, Stein MD. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2008 Sep; 32(9):1652-60.
    View in: PubMed
    Score: 0.023
  30. Gerstein DR, Friedmann PD. Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol. 2008 Apr; 13(3):388-400.
    View in: PubMed
    Score: 0.023
  31. Friedmann PD, Melnick G, Jiang L, Hamilton Z. Violent and disruptive behavior among drug-involved prisoners: relationship with psychiatric symptoms. Behav Sci Law. 2008; 26(4):389-401.
    View in: PubMed
    Score: 0.023
  32. Friedmann PD, Taxman FS, Henderson CE. Evidence-based treatment practices for drug-involved adults in the criminal justice system. J Subst Abuse Treat. 2007 Apr; 32(3):267-77.
    View in: PubMed
    Score: 0.021
  33. Friedmann PD, Alexander JA, Yey Y, Nahra T, Soliman S, Pollack HA. Duration of nonmethadone outpatient treatment: results from a national survey. Subst Abus. 2006 Sep; 27(3):47-53.
    View in: PubMed
    Score: 0.021
  34. Stein MD, Anderson BJ, Lassor J, Friedmann PD. Receipt of disability payments by substance users: mental and physical health correlates. Am J Addict. 2006 Mar-Apr; 15(2):160-5.
    View in: PubMed
    Score: 0.020
  35. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006 Jan; 44(1):8-15.
    View in: PubMed
    Score: 0.020
  36. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005 Nov; 20(11):1038-41.
    View in: PubMed
    Score: 0.019
  37. Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2025 Apr 01; 8(4):e255340.
    View in: PubMed
    Score: 0.019
  38. Jenkins WD, Beach LB, Schneider J, Friedman SR, Pho MT, Walters S, Ezell J, Young AM, Hennessy C, Miller WC, Go VF, Sun C, Seal DW, Westergaard RP, Crane HM, Fredericksen RJ, Ruderman SA, Fletcher S, Ma J, Delaney JA, Plaisance K, Feinberg J, Smith GS, Korthuis PT, Stopka TJ, Friedmann PD, Zule W, Winer M. Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025 Apr; 171:209629.
    View in: PubMed
    Score: 0.018
  39. Jenkins WD, Pho MT, Nance RM, Young AM, Zule W, Stopka TJ, Friedmann PD, Miller WC, Go VF, Korthuis PT, Westergaard R, Seal DW, Feinberg J, Smith GS, Crane HM, Tsui JI, Lanter T, Choudhary V. Influence of insurance type on healthcare utilization among rural people who use drugs. Drug Alcohol Depend. 2025 Apr 01; 269:112542.
    View in: PubMed
    Score: 0.018
  40. Pivovarova E, Planas Garcia BY, Friedmann PD, Stopka TJ, Santelices C, Evans EA. Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers. J Addict Med. 2025 Jan-Feb 01; 19(1):95-101.
    View in: PubMed
    Score: 0.018
  41. Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
    View in: PubMed
    Score: 0.018
  42. Stopka TJ, Whitney BM, de Gijsel D, Brook DL, Friedmann PD, Taylor LE, Feinberg J, Young AM, Evon DM, Herink M, Westergaard R, Koepke R, Havens JR, Zule WA, Delaney JA, Pho MT. Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025 Feb 01; 63(2):77-88.
    View in: PubMed
    Score: 0.018
  43. Ballard AM, Kesich Z, Crane HM, Feinberg J, Friedmann PD, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Seal DW, Smith GS, Stopka TJ, Westergaard RP, Zule WA, Young AM, Cooper HL. Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025 Jan 01; 266:112498.
    View in: PubMed
    Score: 0.018
  44. Stopka TJ, Rottapel R, Friedmann PD, Pivovarova E, Evans EA. Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addict Sci Clin Pract. 2024 Sep 12; 19(1):68.
    View in: PubMed
    Score: 0.018
  45. Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2024 Sep 03; 7(9):e2434704.
    View in: PubMed
    Score: 0.018
  46. Williams AR, Mauro CM, Chiodo L, Huber B, Cruz A, Crystal S, Samples H, Nowels M, Wilson A, Friedmann PD, Remien RH, Olfson M. Buprenorphine treatment and clinical outcomes under the opioid use disorder cascade of care. Drug Alcohol Depend. 2024 Oct 01; 263:112389.
    View in: PubMed
    Score: 0.018
  47. Fredericksen RJ, Mixson LS, Estadt AT, Leichtling G, Bresett J, Zule W, Walters SM, Friedmann PD, Romo E, Whitney BM, Delaney JAC, Crane HM, Tsui JI, Young A, Seal D, Stopka TJ. Barriers to retention in inpatient and residential drug treatment among persons who use opioids and/or injection drugs living in the rural U.S. J Subst Use Addict Treat. 2024 Oct; 165:209453.
    View in: PubMed
    Score: 0.018
  48. Evans SK, Ober AJ, Korn AR, Peltz A, Friedmann PD, Page K, Murray-Krezan C, Huerta S, Ryzewicz SJ, Tarhuni L, Nuckols TK, E Watkins K, Danovitch I. Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder. Addict Sci Clin Pract. 2024 04 26; 19(1):31.
    View in: PubMed
    Score: 0.018
  49. Rudolph AE, Nance RM, Bobashev G, Brook D, Akhtar W, Cook R, Cooper HL, Friedmann PD, Frost SDW, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Ruderman SA, Seal DW, Stopka TJ, Westergaard RP, Young AM, Zule WA, Tsui JI, Crane HM, Whitney BM, Delaney JAC. Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations: findings from the Rural Opioid Initiative. BMC Med Res Methodol. 2024 Apr 23; 24(1):94.
    View in: PubMed
    Score: 0.018
  50. Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes. JAMA Netw Open. 2024 03 04; 7(3):e242732.
    View in: PubMed
    Score: 0.017
  51. Stopka TJ, Estadt AT, Leichtling G, Schleicher JC, Mixson LS, Bresett J, Romo E, Dowd P, Walters SM, Young AM, Zule W, Friedmann PD, Go VF, Baker R, Fredericksen RJ. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study. Soc Sci Med. 2024 04; 346:116660.
    View in: PubMed
    Score: 0.017
  52. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs. J Behav Health Serv Res. 2004 Jan-Mar; 31(1):86-97.
    View in: PubMed
    Score: 0.017
  53. Hoover DB, Korthuis PT, Waddell EN, Foot C, Conway C, Crane HM, Friedmann PD, Go VF, Nance RM, Pho MT, Satcher MF, Sibley A, Westergaard RP, Young AM, Cook R. Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities. JAMA Netw Open. 2023 11 01; 6(11):e2342222.
    View in: PubMed
    Score: 0.017
  54. Friedmann PD, Lemon SC, Anderson BJ, Stein MD. Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug Alcohol Depend. 2003 Apr 01; 69(3):243-51.
    View in: PubMed
    Score: 0.016
  55. Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003 Jan; 18(1):1-8.
    View in: PubMed
    Score: 0.016
  56. Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Community referral sources and entry of treatment-naive clients into outpatient addiction treatment. Am J Drug Alcohol Abuse. 2003; 29(1):105-15.
    View in: PubMed
    Score: 0.016
  57. Fernandez AC, Chapman L, Ren TY, Baxley C, Hallway AK, Tang MJ, Waljee JF, Friedmann PD, Mello M, Borsari B, Blow F. Preoperative alcohol interventions for elective surgical patients: Results from a randomized pilot trial. Surgery. 2022 12; 172(6):1673-1681.
    View in: PubMed
    Score: 0.016
  58. Elliott L, Nerney M, Jones T, Friedmann PD. Barriers to screening for domestic violence. J Gen Intern Med. 2002 Feb; 17(2):112-6.
    View in: PubMed
    Score: 0.015
  59. Stein MD, Anderson B, Charuvastra A, Maksad J, Friedmann PD. A brief intervention for hazardous drinkers in a needle exchange program. J Subst Abuse Treat. 2002 Jan; 22(1):23-31.
    View in: PubMed
    Score: 0.015
  60. McGarry KA, Stein MD, Clarke JG, Friedmann PD. Utilization of preventive health services by HIV-seronegative injection drug users. J Addict Dis. 2002; 21(2):93-102.
    View in: PubMed
    Score: 0.015
  61. Stein MD, Friedmann P. Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance. Am J Addict. 2002; 11(4):262-70.
    View in: PubMed
    Score: 0.015
  62. Stein MD, Anderson B, Charuvastra A, Friedmann PD. Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange. Alcohol Clin Exp Res. 2001 Oct; 25(10):1487-93.
    View in: PubMed
    Score: 0.015
  63. Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001 Sep 01; 64(1):47-53.
    View in: PubMed
    Score: 0.015
  64. Friedmann PD, Lemon SC, Stein MD. Transportation and retention in outpatient drug abuse treatment programs. J Subst Abuse Treat. 2001 Sep; 21(2):97-103.
    View in: PubMed
    Score: 0.015
  65. Friedmann PD, Saitz R, Gogineni A, Zhang JX, Stein MD. Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems". J Stud Alcohol. 2001 Mar; 62(2):234-8.
    View in: PubMed
    Score: 0.014
  66. Nolte K, Drew AL, Friedmann PD, Romo E, Kinney LM, Stopka TJ. Opioid initiation and injection transition in rural northern New England: A mixed-methods approach. Drug Alcohol Depend. 2020 12 01; 217:108256.
    View in: PubMed
    Score: 0.014
  67. Friedmann PD, McCullough D, Chin MH, Saitz R. Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med. 2000 Feb; 15(2):84-91.
    View in: PubMed
    Score: 0.013
  68. Peacock-Chambers E, Leyenaar JK, Foss S, Feinberg E, Wilson D, Friedmann PD, Visintainer P, Singh R. Early Intervention Referral and Enrollment Among Infants with Neonatal Abstinence Syndrome. J Dev Behav Pediatr. 2019 Jul/Aug; 40(6):441-450.
    View in: PubMed
    Score: 0.013
  69. Friedmann PD, Alexander JA, Jin L, D'Aunno TA. On-site primary care and mental health services in outpatient drug abuse treatment units. J Behav Health Serv Res. 1999 Feb; 26(1):80-94.
    View in: PubMed
    Score: 0.012
  70. Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA. 1998 Apr 15; 279(15):1227-31.
    View in: PubMed
    Score: 0.012
  71. Friedmann PD, Samore MH. Diagnostic characteristics of cerebrospinal fluid analysis for secondary menigitis in HIV-infected adults. J Investig Med. 1998 Apr; 46(4):153-60.
    View in: PubMed
    Score: 0.012
  72. Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, O'Brien CP. Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision. J Empir Res Hum Res Ethics. 2018 04; 13(2):160-172.
    View in: PubMed
    Score: 0.011
  73. Allen AA, Chen DT, Bonnie RJ, Ko TM, Suratt CE, Lee JD, Friedmann PD, Gordon M, McDonald R, Murphy SM, Boney TY, Nunes EV, O'Brien CP. Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision. J Subst Abuse Treat. 2017 10; 81:66-72.
    View in: PubMed
    Score: 0.011
  74. Kaufman JL, Garb JL, Berman JA, Rhee SW, Norris MA, Friedmann P. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter? J Am Coll Surg. 1997 Jul; 185(1):74-9.
    View in: PubMed
    Score: 0.011
  75. Nunes EV, Gordon M, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hu MC, Boney TY, Wilson D, O'Brien CP. Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. J Subst Abuse Treat. 2018 02; 85:49-55.
    View in: PubMed
    Score: 0.011
  76. Murphy SM, Polsky D, Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Bonnie RJ, Gordon M, Chen DT, Boney TY, O'Brien CP. Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction. 2017 Aug; 112(8):1440-1450.
    View in: PubMed
    Score: 0.011
  77. Yaffe HC, Friedmann P, Kayler LK. Very small pediatric donor kidney transplantation in pediatric recipients. Pediatr Transplant. 2017 Aug; 21(5).
    View in: PubMed
    Score: 0.011
  78. Kaufman JL, Frank D, Rhee SW, Berman JA, Friedmann P. Feasibility and safety of 1-day postoperative hospitalization for carotid endarterectomy. Arch Surg. 1996 Jul; 131(7):751-5.
    View in: PubMed
    Score: 0.010
  79. Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, O'Brien CP. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. N Engl J Med. 2016 Mar 31; 374(13):1232-42.
    View in: PubMed
    Score: 0.010
  80. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med. 1996 Feb 15; 124(4):414-21.
    View in: PubMed
    Score: 0.010
  81. Christopher PP, Stein MD, Johnson JE, Rich JD, Friedmann PD, Clarke J, Lidz CW. Exploitation of Prisoners in Clinical Research: Perceptions of Study Participants. IRB. 2016 Jan-Feb; 38(1):7-12.
    View in: PubMed
    Score: 0.010
  82. Friedmann PD, Samore MH, Kraemer KL, Calkins DR. Clinical correlates of secondary meningitis in HIV-infected adults. Arch Intern Med. 1995 Nov 13; 155(20):2231-7.
    View in: PubMed
    Score: 0.010
  83. Lee JD, Friedmann PD, Boney TY, Hoskinson RA, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O'Brien CP. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemp Clin Trials. 2015 Mar; 41:110-7.
    View in: PubMed
    Score: 0.009
  84. Lantini R, van den Berg JJ, Roberts MB, Bock BC, Stein LA, Parker DR, Friedmann PD, Clarke JG. Characteristics of smoking used cigarettes among an incarcerated population. Psychol Addict Behav. 2015 Mar; 29(1):254-8.
    View in: PubMed
    Score: 0.009
  85. van den Berg JJ, Bock B, Roberts MB, Stein LA, Friedmann PD, Martin SA, Clarke JG. Cigarette smoking as an expression of independence and freedom among inmates in a tobacco-free prison in the United States. Nicotine Tob Res. 2014 Feb; 16(2):238-42.
    View in: PubMed
    Score: 0.008
  86. Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abuse Treat. 2013 Aug; 45(2):222-6.
    View in: PubMed
    Score: 0.008
  87. Cupertino AP, Hunt JJ, Gajewski BJ, Jiang Y, Marquis J, Friedmann PD, Engelman KK, Richter KP. The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities. Subst Abuse Treat Prev Policy. 2013 Mar 15; 8:13.
    View in: PubMed
    Score: 0.008
  88. Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy? J Addict Med. 2012 Sep; 6(3):179-85.
    View in: PubMed
    Score: 0.008
  89. Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths among former inmates. J Addict Med. 2012 Jun; 6(2):97-105.
    View in: PubMed
    Score: 0.008
  90. Pirraglia PA, Rowland E, Wu WC, Friedmann PD, O'Toole TP, Cohen LB, Taveira TH. Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. Prev Chronic Dis. 2012; 9:E51.
    View in: PubMed
    Score: 0.008
  91. McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Subst Abus. 2012; 33(1):19-29.
    View in: PubMed
    Score: 0.007
  92. Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O'Brien CP. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus. 2012; 33(1):48-59.
    View in: PubMed
    Score: 0.007
  93. Hunt JJ, Cupertino AP, Garrett S, Friedmann PD, Richter KP. How is tobacco treatment provided during drug treatment? J Subst Abuse Treat. 2012 Jan; 42(1):4-15.
    View in: PubMed
    Score: 0.007
  94. Johnson JE, Friedmann PD, Green TC, Harrington M, Taxman FS. Gender and treatment response in substance use treatment-mandated parolees. J Subst Abuse Treat. 2011 Apr; 40(3):313-21.
    View in: PubMed
    Score: 0.007
  95. Cioe PA, Friedmann PD, Stein MD. Erectile dysfunction in opioid users: lack of association with serum testosterone. J Addict Dis. 2010 Oct; 29(4):455-60.
    View in: PubMed
    Score: 0.007
  96. Celoria G, Steingrub JS, Vickers-Lahti M, Teres D, Stein KL, Fink M, Friedmann P. Clinical assessment of hemodynamic values in two surgical intensive care units. Effects on therapy. Arch Surg. 1990 Aug; 125(8):1036-9.
    View in: PubMed
    Score: 0.007
  97. Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ. Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. J Subst Abuse Treat. 2010 Sep; 39(2):157-66.
    View in: PubMed
    Score: 0.007
  98. Stein MD, Anderson BJ, Caviness CM, Rosengard C, Kiene S, Friedmann P, Clarke JG. Relationship of alcohol use and sexual risk taking among hazardously drinking incarcerated women: an event-level analysis. J Stud Alcohol Drugs. 2009 Jul; 70(4):508-15.
    View in: PubMed
    Score: 0.006
  99. Caviness CM, Hatgis C, Anderson BJ, Rosengard C, Kiene SM, Friedmann PD, Stein MD. Three brief alcohol screens for detecting hazardous drinking in incarcerated women. J Stud Alcohol Drugs. 2009 Jan; 70(1):50-4.
    View in: PubMed
    Score: 0.006
  100. Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C. Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behav Sci Law. 2009 Jan-Feb; 27(1):51-69.
    View in: PubMed
    Score: 0.006
  101. Rhodes AG, Taxman FS, Friedmann PD, Cropsey KL. HCV in incarcerated populations: an analysis of gender and criminality on risk. J Psychoactive Drugs. 2008 Dec; 40(4):493-501.
    View in: PubMed
    Score: 0.006
  102. Friedmann P, Garb JL, Berman J, Sullivan C, Celoria G, Rhee SW. Carotid endarterectomy. Clinical results in a community-based teaching hospital. Stroke. 1988 Nov; 19(11):1323-7.
    View in: PubMed
    Score: 0.006
  103. Zlotnick C, Clarke JG, Friedmann PD, Roberts MB, Sacks S, Melnick G. Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs. Behav Sci Law. 2008; 26(4):403-12.
    View in: PubMed
    Score: 0.006
  104. Hebert MR, Clarke JG, Caviness CM, Ray MK, Friedmann PD, Stein MD. Feasibility of gaining access to women in jail for health interventions. Women Health. 2008; 47(3):79-93.
    View in: PubMed
    Score: 0.006
  105. Layton D, Marshall V, Boshier A, Friedmann P, Shakir SA. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England. Drug Saf. 2006; 29(8):687-96.
    View in: PubMed
    Score: 0.005
  106. Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addict Behav. 2003 Sep; 28(7):1323-31.
    View in: PubMed
    Score: 0.004
  107. Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003 May; 98(5):673-84.
    View in: PubMed
    Score: 0.004
  108. Kertesz SG, Horton NJ, Friedmann PD, Saitz R, Samet JH. Slowing the revolving door: stabilization programs reduce homeless persons' substance use after detoxification. J Subst Abuse Treat. 2003 Apr; 24(3):197-207.
    View in: PubMed
    Score: 0.004
  109. Saitz R, Friedmann PD, Sullivan LM, Winter MR, Lloyd-Travaglini C, Moskowitz MA, Samet JH. Professional satisfaction experienced when caring for substance-abusing patients: faculty and resident physician perspectives. J Gen Intern Med. 2002 May; 17(5):373-6.
    View in: PubMed
    Score: 0.004
  110. Lubelczyk RA, Friedmann PD, Lemon SC, Stein MD, Gerstein DR. HIV prevention services in correctional drug treatment programs: do they change risk behaviors? AIDS Educ Prev. 2002 Apr; 14(2):117-25.
    View in: PubMed
    Score: 0.004
  111. Charuvastra A, Anderson BJ, Friedmann PD, Stein MD. Perceived addiction treatment needs among alcohol using injection drug users. J Addict Dis. 2002; 21(4):93-107.
    View in: PubMed
    Score: 0.004
  112. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001 Jan 08; 161(1):85-91.
    View in: PubMed
    Score: 0.003
  113. Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, Torian L, Glebatis D, Murrill C, Monterroso E, Friedman SR. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000 Mar; 90(3):352-9.
    View in: PubMed
    Score: 0.003
  114. Salomon N, Perlman DC, Friedmann P, Ziluck V, Des Jarlais DC. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis. 2000 Jan; 4(1):47-54.
    View in: PubMed
    Score: 0.003
  115. Salomon N, Perlman DC, Friedmann P, Perkins MP, Ziluck V, Jarlais DC, Paone D. Knowledge of tuberculosis among drug users. Relationship to return rates for tuberculosis screening at a syringe exchange. J Subst Abuse Treat. 1999 Apr; 16(3):229-35.
    View in: PubMed
    Score: 0.003
  116. Friedmann P, Park WC, Afonya II, Chabot JR, Garb JL, Pace OT, Emery RW. Adjuvant radiation therapy in colorectal carcinoma. Am J Surg. 1978 Apr; 135(4):512-8.
    View in: PubMed
    Score: 0.003
  117. Des Jarlais DC, Vanichseni S, Marmor M, Buavirat A, Titus S, Raktham S, Friedmann P, Kitayaporn D, Wolfe H, Friedman SR, Mastro TD. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15; 16(5):393-9.
    View in: PubMed
    Score: 0.003
  118. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997 Sep; 12(9):523-30.
    View in: PubMed
    Score: 0.003
  119. Woods K, Karrison T, Koshy M, Patel A, Friedmann P, Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep. 1997 Jan-Feb; 112(1):44-51.
    View in: PubMed
    Score: 0.003
  120. Perlman DC, Perkins MP, Paone D, Kochems L, Salomon N, Friedmann P, Des Jarlais DC. "Shotgunning" as an illicit drug smoking practice. J Subst Abuse Treat. 1997 Jan-Feb; 14(1):3-9.
    View in: PubMed
    Score: 0.003
  121. Des Jarlais DC, Friedmann P, Hagan H, Friedman SR. The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use. Am J Public Health. 1996 Dec; 86(12):1780-5.
    View in: PubMed
    Score: 0.003
  122. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis. 1995 Nov; 21(5):1245-52.
    View in: PubMed
    Score: 0.002
  123. Des Jarlais DC, Friedman SR, Friedmann P, Wenston J, Sotheran JL, Choopanya K, Vanichseni S, Raktham S, Goldberg D, Frischer M, et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS. 1995 Jun; 9(6):611-7.
    View in: PubMed
    Score: 0.002
  124. Chavkin W, Paone D, Friedmann P, Wilets I. Psychiatric histories of drug using mothers: treatment implications. J Subst Abuse Treat. 1993 Sep-Oct; 10(5):445-8.
    View in: PubMed
    Score: 0.002
  125. Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS. 1993 Jun; 7(6):887-91.
    View in: PubMed
    Score: 0.002
  126. Chavkin W, Paone D, Friedmann P, Wilets I. Reframing the debate: toward effective treatment for inner city drug-abusing mothers. Bull N Y Acad Med. 1993; 70(1):50-68.
    View in: PubMed
    Score: 0.002
  127. Vanichseni S, Choopanya K, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr (1988). 1992; 5(11):1119-23.
    View in: PubMed
    Score: 0.002
  128. Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991 Dec; 5(12):1509-13.
    View in: PubMed
    Score: 0.002
  129. Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991 Sep; 81(9):1185-91.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.